(Q64171181)
Statements
FACT LTS & OA (English)
0 references
A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip (English)
0 references
17 February 2016
0 references
1 August 2021
0 references
7,000
0 references
18 year
0 references